Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Tumorigenesis Driven by BRAF^V600E Requires Secondary Mutations That Overcome Its Feedback Inhibition of RAC1 and Migration

Sunyana Gadal, Jacob A. Boyer, Simon F. Roy, Noah A. Outmezguine, Malvika Sharma, Hongyan Li, Ning Fan, Eric Chan, Yevgeniy Romin, Afsar Barlas, Qing Chang, Priya Pancholi, Neilawattie Merna Timaul, Michael Overholtzer, Rona Yaeger, Katia Manova-Todorova, Elisa de Stanchina, Marcus W. Bosenberg, Neal Rosen

Cancer Res (2025) 85 (9): 1611–1627.

https://doi.org/10.1158/0008-5472.CAN-24-2220

Published: 02 May 2025

View articletitled, Tumorigenesis Driven by BRAFV600E Requires Secondary Mutations That Overcome Its Feedback Inhibition of RAC1 and Migration

Includes: Multimedia, Supplementary data

Journal Articles

Abstract 4723: Development and preclinical activity of BSI-721, a novel antibody-drug conjugate (ADC) targeting cadherin 17 (CDH17) in gastrointestinal cancers

Xiaoyao Hao, Jingyu Liu, hongyan li, jun li, jialong wang, Hui-Han Hu, frank liu, mingjiu chen, Qun Lv

Cancer Res (2025) 85 (8_Supplement_1): 4723.

https://doi.org/10.1158/1538-7445.AM2025-4723

Published: 21 April 2025

View articletitled, Abstract 4723: Development and preclinical activity of BSI-721, a novel antibody-drug conjugate (ADC) targeting cadherin 17 (CDH17) in gastrointestinal cancers

Journal Articles

Abstract 3135: BSI-730, a bispecific antibody targeting HER2 and PD-L1 for the development of a first-in-class bispecific ADC

Xiaoyao Hao, Hongyan Li, Xiaodong F. Liu, Jinyu Liu, Wenwen Dai, Ying Pan, Hui-Han Hu, Jun Li, Shukai Xia, Qun Lyu, Hugh M. Davis, Mingjiu Chen, Zeyu Peng

Cancer Res (2024) 84 (6_Supplement): 3135.

https://doi.org/10.1158/1538-7445.AM2024-3135

Published: 22 March 2024

View articletitled, Abstract 3135: BSI-730, a bispecific antibody targeting HER2 and PD-L1 for the development of a first-in-class bispecific ADC

Journal Articles

Abstract 5298: BSI-093, a best-in-class anti-BTN3A monoclonal antibody for cancer immunotherapy by activation of Vg9Vd2 T cells

Wenwen Dai, Jun Li, Jinyu Liu, Hongyan Li, Xiaodong F. Liu, Shukai Xia, Qun Lyu, Hugh M. Davis, Mingjiu Chen, Zeyu Peng

Cancer Res (2024) 84 (6_Supplement): 5298.

https://doi.org/10.1158/1538-7445.AM2024-5298

Published: 22 March 2024

View articletitled, Abstract 5298: BSI-093, a best-in-class anti-BTN3A monoclonal antibody for cancer immunotherapy by activation of Vg9Vd2 T cells

Journal Articles

Abstract 1343: BSI-111, a highly selective anti-CD16a monoclonal antibody with potent agonist activity for building a NK cell engager platform

Jinyu Liu, Wenwen Dai, Hongyan Li, Xiaodong F. Liu, Jun Li, Shukai Xia, Qun Lyu, Hugh M. Davis, Mingjiu Chen, Zeyu Peng

Cancer Res (2024) 84 (6_Supplement): 1343.

https://doi.org/10.1158/1538-7445.AM2024-1343

Published: 22 March 2024

View articletitled, Abstract 1343: BSI-111, a highly selective anti-CD16a monoclonal antibody with potent agonist activity for building a NK cell engager platform

Journal Articles

Abstract 6367: BSI-507, a first-in-class bispecific antibody targeting PD1 and PVRIG for cancer immunotherapy

Zeyu Peng, Xiaodong F. Liu, Hongyan Li, Wenwen Dai, Jinyu Liu, Xiaoyao Hao, Shukai Xia, Qun Lv, Hugh M. Davis, Mingjiu Chen, Mark Z. Ma

Cancer Res (2023) 83 (7_Supplement): 6367.

https://doi.org/10.1158/1538-7445.AM2023-6367

Published: 04 April 2023

View articletitled, Abstract 6367: BSI-507, a first-in-class bispecific antibody targeting PD1 and PVRIG for cancer immunotherapy

Journal Articles

Abstract 2958: BSI-508, a novel bispecific fusion molecule targeting PD1 and CD47 for cancer immunotherapy

Zeyu Peng, Xiaodong F. Liu, Hongyan Li, Wenwen Dai, Jinyu Liu, Xiaoyao Hao, Shukai Xia, Qun Lv, Hugh M. Davis, Mingjiu Chen, Mark Z. Ma

Cancer Res (2023) 83 (7_Supplement): 2958.

https://doi.org/10.1158/1538-7445.AM2023-2958

Published: 04 April 2023

View articletitled, Abstract 2958: BSI-508, a novel bispecific fusion molecule targeting PD1 and CD47 for cancer immunotherapy

Journal Articles

Abstract 5290: BSI-001, a novel anti-HER2 antibody exhibiting potent synergistic efficacy with trastuzumab

Shukai Xia, Zeyu Peng, Xiaoyu Ding, Wanjian Gu, Yujie Zhong, Jinyu Liu, Hongyan Li, Xiaoyao Hao, Xiaodong F. Liu, Mark Z. Ma, Lan Luo, Chunni Zhang, Mingjiu Chen

Cancer Res (2022) 82 (12_Supplement): 5290.

https://doi.org/10.1158/1538-7445.AM2022-5290

Published: 15 June 2022

View articletitled, Abstract 5290: BSI-001, a novel anti-HER2 antibody exhibiting potent synergistic efficacy with trastuzumab

Journal Articles

Abstract 5522: BSI-060T, a high affinity, fully human anti-siglec-15 antibody as an alternative immune checkpoint blocker

Zeyu Peng, Xiaodong F. Liu, Shukai Xia, Jinyu Liu, Hongyan Li, Yuxiang Liu, Hugh M. Davis, Mingjiu Chen, Mark Z. Ma

Cancer Res (2022) 82 (12_Supplement): 5522.

https://doi.org/10.1158/1538-7445.AM2022-5522

Published: 15 June 2022

View articletitled, Abstract 5522: BSI-060T, a high affinity, fully human anti-siglec-15 antibody as an alternative immune checkpoint blocker

Journal Articles

Abstract 2422: Migration of V600E-expressing cells is suppressed by ERK-dependent feedback inhibition of RAC1 and rescued in melanoma by secondary mutations

Sunyana Gadal, Jacob A. Boyer, Hongyan Li, Ning Fan, Eric Chan, Yevgeniy Romin, Elisa De Stanchina, Rona Yeager, Marcus Bosenberg, Katia M. Todorova, Neal Rosen

Cancer Res (2022) 82 (12_Supplement): 2422.

https://doi.org/10.1158/1538-7445.AM2022-2422

Published: 15 June 2022

View articletitled, Abstract 2422: Migration of V600E-expressing cells is suppressed by ERK-dependent feedback inhibition of RAC1 and rescued in melanoma by secondary mutations

Journal Articles

Abstract 5312: BSI-082, a fully human anti-SIRPα antibody with both high specificity and broad coverage of SIRPα variant populations

Zeyu Peng, Jinyu Liu, Wenwen Dai, Xiaodong F. Liu, Shukai Xia, Hongyan Li, Lei Shi, Hugh M. Davis, Mingjiu Chen, Mark Z. Ma

Cancer Res (2022) 82 (12_Supplement): 5312.

https://doi.org/10.1158/1538-7445.AM2022-5312

Published: 15 June 2022

View articletitled, Abstract 5312: BSI-082, a fully human anti-SIRPα antibody with both high specificity and broad coverage of SIRPα variant populations

Journal Articles

Abstract 704: Development of a patient-derived xenograft (PDX) modeling program to enable pediatric precision medicine

Filemon S. Dela Cruz, Joseph G. McCarter, Daoqi You, Nancy Bouvier, Xinyi Wang, Kristina C. Guillan, Armaan H. Siddiquee, Katie B. Souto, Hongyan Li, Teng Gao, Dominik Glodzik, Daniel Diolaiti, Neerav N. Shukla, Joachim Silber, Umeshkumar K. Bhanot, Faruk Erdem Kombak, Diego F. Coutinho, Shanita Li, Juan E. Arango Ossa, Juan S. Medina-Martinez, Michael V. Ortiz, Emily K. Slotkin, Michael D. Kinnaman, Sameer F. Sait, Tara J. O'Donohue, Marissa Mattar, Maximiliano Meneses, Michael P. LaQuaglia, Todd E. Heaton, Justin T. Gerstle, Nicola Fabbri, Chelsey M. Burke, Irene M. Rodriquez-Sanchez, Christine A. Iacobuzio-Donahue, Julia L. Glade Bender, Ryan D. Roberts, Jason T. Yustein, Nino C. Rainusso, Brian D. Crompton, Elizabeth Stewart, Alejandro Sweet-Cordero, Leanne C. Sayles, Andrika D. Thomas, Michael H. Roehrl, Elisa de Stanchina, Elli Papaemmanuil, Andrew L. Kung

Cancer Res (2022) 82 (12_Supplement): 704.

https://doi.org/10.1158/1538-7445.AM2022-704

Published: 15 June 2022

View articletitled, Abstract 704: Development of a patient-derived xenograft (PDX) modeling program to enable pediatric precision medicine

Journal Articles

Abstract 3735: An anti-tumor immune response is evoked by partial-volume single dose radiation

Adriana Haimovitz-Friedman, Johnn Humm, Joseph O. Deasy, Jedd Wolchok, Taha Merghoub, James Russell, Hongyan Li, Robert Samstein, Sadna Budhu, Simon Powell, Chloe Bodden, Ela Markovsky, Qing Chen

Cancer Res (2019) 79 (13_Supplement): 3735.

https://doi.org/10.1158/1538-7445.AM2019-3735

Published: 01 July 2019

View articletitled, Abstract 3735: An anti-tumor immune response is evoked by partial-volume single dose radiation

Journal Articles

Abstract 3347: Radiation-induced gastrointestinal (GI) syndrome as a function of age

Hongyan Li, Herman Kucharavy, Carla Hajj, Guoqiang Hua, Ryan Glass, Zhaoshi Zeng, Zvi Fuks, Philip B. Paty, Richard Kolesnick, Karen Hubbard, Adriana Haimovitz-Friedman

Cancer Res (2015) 75 (15_Supplement): 3347.

https://doi.org/10.1158/1538-7445.AM2015-3347

Published: 01 August 2015

View articletitled, Abstract 3347: Radiation-induced gastrointestinal (GI) syndrome as a function of age

Journal Articles

Discovery of cancer biomarkers by mass-tagging with iTRAQ and multidimensional LC-MS/MS and verification by immunochemistry

Leroi DeSouza, Joerg Grigull, Shaun Ghanny, Valerie Dube, Hongyan Li, Wei Li, Joydeep Mukherjee, Abhijit Guha, Ranju Ralhan, Alexander Romaschin, Terence Colgan, K. W. Michael Siu

Cancer Res (2007) 67 (9_Supplement): 3149.

Published: 01 May 2007

View articletitled, Discovery of cancer biomarkers by mass-tagging with iTRAQ and multidimensional LC-MS/MS and verification by immunochemistry

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Tumorigenesis Driven by BRAF^V600E Requires Secondary Mutations That Overcome Its Feedback Inhibition of RAC1 and Migration

Abstract 4723: Development and preclinical activity of BSI-721, a novel antibody-drug conjugate (ADC) targeting cadherin 17 (CDH17) in gastrointestinal cancers

Abstract 3135: BSI-730, a bispecific antibody targeting HER2 and PD-L1 for the development of a first-in-class bispecific ADC

Abstract 5298: BSI-093, a best-in-class anti-BTN3A monoclonal antibody for cancer immunotherapy by activation of Vg9Vd2 T cells

Abstract 1343: BSI-111, a highly selective anti-CD16a monoclonal antibody with potent agonist activity for building a NK cell engager platform

Abstract 6367: BSI-507, a first-in-class bispecific antibody targeting PD1 and PVRIG for cancer immunotherapy

Abstract 2958: BSI-508, a novel bispecific fusion molecule targeting PD1 and CD47 for cancer immunotherapy

Abstract 5290: BSI-001, a novel anti-HER2 antibody exhibiting potent synergistic efficacy with trastuzumab

Abstract 5522: BSI-060T, a high affinity, fully human anti-siglec-15 antibody as an alternative immune checkpoint blocker

Abstract 2422: Migration of V600E-expressing cells is suppressed by ERK-dependent feedback inhibition of RAC1 and rescued in melanoma by secondary mutations

Abstract 5312: BSI-082, a fully human anti-SIRPα antibody with both high specificity and broad coverage of SIRPα variant populations

Abstract 704: Development of a patient-derived xenograft (PDX) modeling program to enable pediatric precision medicine

Abstract 3735: An anti-tumor immune response is evoked by partial-volume single dose radiation

Abstract 3347: Radiation-induced gastrointestinal (GI) syndrome as a function of age

Discovery of cancer biomarkers by mass-tagging with iTRAQ and multidimensional LC-MS/MS and verification by immunochemistry

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only